🔴 Rezolute is trading 5% down with no clear catalyst identified

Rezolute is trading 5.08% down now at $4.01, with no reliable report linking the decline to a new company event.

• The price context shows a further decline from the October 14 close of $4.23.
• Rezolute announced October 14 that enrollment in its Phase 3 upLIFT study was complete; topline results are expected in mid-December. This positive milestone is not an evident explanation for the drop.
• A report cites a Zacks rating cut in a research note dated Tuesday, but its timing and connection to the decline are unclear.